LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 268 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $65,000 | -4.4% | 900 | +50.0% | 0.03% | +65.0% |
Q2 2019 | $68,000 | +25.9% | 600 | +50.0% | 0.02% | +17.6% |
Q4 2018 | $54,000 | -82.1% | 400 | -63.6% | 0.02% | -70.2% |
Q3 2018 | $301,000 | -27.6% | 1,100 | -45.0% | 0.06% | -40.0% |
Q2 2018 | $416,000 | -4.8% | 2,000 | -25.9% | 0.10% | -12.0% |
Q1 2018 | $437,000 | +355.2% | 2,700 | +285.7% | 0.11% | +390.9% |
Q4 2017 | $96,000 | -78.6% | 700 | -78.8% | 0.02% | -77.8% |
Q3 2017 | $449,000 | -15.9% | 3,300 | -25.0% | 0.10% | +26.9% |
Q2 2017 | $534,000 | -23.6% | 4,400 | -33.3% | 0.08% | -2.5% |
Q1 2017 | $699,000 | -3.1% | 6,600 | -7.0% | 0.08% | -12.1% |
Q4 2016 | $721,000 | +33.3% | 7,100 | +34.0% | 0.09% | +30.0% |
Q3 2016 | $541,000 | +37.3% | 5,300 | +60.6% | 0.07% | +27.3% |
Q2 2016 | $394,000 | – | 3,300 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |